Abstract
A new class of surface-modified silica nanoparticles has been developed for potential applications in boron neutron capture therapy. Sub-50 nm silica particles were synthesized using a modified Stöber method and used in surface-initiated atom transfer radical polymerization of two biocompatible polymers, poly(2-(hydroxyethyl)methacrylate) and poly(2-(methacryloyloxy)ethyl succinate). The carboxylic acid and hydroxyl functionalities of the polymeric side chains were functionalized with carboranyl clusters in high yields. The resulting particles were characterized using DLS, TEM, solution 1H NMR, solid state 11B NMR and thermogravimetric analysis. The particles contain between 13 and 18 % of boron atoms by weight, which would provide a high amount of 10B nuclides for BNCT, while the polymer chains are suitable for further modification with cell targeting ligands.
Similar content being viewed by others
References
Barth RF, Adams DM, Soloway AH, Alam F, Darby MV (1994) Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. Bioconjugate Chem 5:58–66
Bregadze VI, Sivaev IB, Glazun SA (2006) Polyhedral boron compounds as potential diagnostic and therapeutic antitumor agents. Anti-Cancer Agents in Med Chem 6:75–109
Ceberg CP, Brun A, Kahl SB, Koo MS, Persson BR, Salford LG (1995) A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J Neurosurg 83:86–92
Diaz A, Stelzer K, Laramore G, Wiersema R (2002) In: Sauerwein W, Moss R, Witting A (eds) Research and development in neutron capture therapy. Bologna, Monduzzi Editore, pp 993–994
Feakes DA, Shelly K, Hawthorne MF (1995) Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc Natl Acad Sci USA 92:1367–1370
Fréchet JMJ, Tomalia DA (2001) Dendrimers and other dendritic polymers. Wiley, New York
Friedlander G, Kennedy JW, Macias ES, Miller JM (1981) Nuclear and radiochemistry. Wiley, New York
Galie KM, Mollard A, Zharov I (2006) Polyester-based carborane-containing dendrons. Inorg Chem 45:7815–7820
Gedda L, Olsson P, Ponten J, Carlsson J (1996) Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Bioconjug Chem 7:584–591
Gratton SEA, Parrott MC, Adronov A (2005) Preparation of carborane-containing polymers by atom transfer radical polymerization. J Inorg Organomet Polym 15:469–475
Hao E, Friso E, Miotto G, Jori G, Soncin M, Fabris C, Sabrian-Vazquez M, Vicente MGH (2008) Synthesis and biological investigations of tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC). Org Biolmol Chem 6:3732–3740
Hatanaka HA (1975) A revised boron-neutron capture therapy for malignant brain tumors. II. Interim clinical result with the patients excluding previous treatments. J Neurol 209:81–94
Hawthorne MF (1993) The role of chemistry in the development of cancer therapy by the boron-neutron capture reaction. Angew Chem Int Ed 32:950–984
Hoffman AS (2002) Hydrogels for biomedical applications. Adv Drug Delivery Rev 54:3–12
Isaac MF, Khal SB (2003) Synthesis of ether- and carbon-linked polycarboranyl porphyrin dimers for cancer therapies. J Organomet Chem 680:232–243
Jain P, Dai J, Baker GL, Bruening ML (2008) Rapid synthesis of functional polymer brushes by surface-initiated atom transfer radical polymerization of an acidic monomer. Macromolecules 41:8413–8417
Javid M, Brownell GL, Sweet WH (1952) The possible use of neutron-capturing isotopes such as boron10 in the treatment of neoplasms. II. Computation of the radiation energies and estimates of effects in normal and neoplastic brain. J Clin Invest 31:604–610
Kabalka GW, Yao ML (2003) Synthesis of a potential boron neutron capture therapy agent: 1-aminocyclobutane-1-carboxylic acid bearing a butylboronic acid side chain. Synthesis 18:2890–2893
Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M, Yura Y (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61:1069–1073
Koivunoro H, Bleue DLl, Nastasi U, Lou TP, Reijonen J, Leung JN (2004) BNCT dose distribution in liver with epithermal D-D and D-T fusion-based neutron beams. Appl Radiat Isot 61:853–859
Kolonin MG, Pasqualini R, Arap W (2009) Tissue-specific targeting based on markers expressed outside endothelial cells. Adv Genetics 67:61–102
Kueffer PJ, Maitz CA, Khan AA, Schuster SA, Shlyakhtina NI, Jalisatgi SS, Brockman JD, Nigg DW, Hawthorne MF (2013) Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes. Proc Natl Acad Sci USA. doi:10.1073/pnas.1303437110
Lee JD, Ueno M, Miyajima Y, Nakamura H (2007) Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. Org Lett 9:323–326
Li T, Hamdi J, Hawthorne MF (2006) Unilamellar liposomes with enhanced boron content. Bioconjug Chem 17:15–20
Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R (2000) Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Controlled Release 68:299–302
Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara M, Chiba M, Kobayashi H, Eriguchi M, Yanagie H (2004) Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release 98:195–207
Matyjaszewski K, Xia J (2001) Atom transfer tadical polymerization. Chem Rev 101:2921–2990
Meo CD, Panza L, Capitani D, Mannia L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V (2007) Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy. Biomacromolecules 8:552–559
Mishima Y, Honda C, Ichihasi M, Obara H, Hiratsuka J, Fukuda H, Karashima H, Kobayaki T, Kanda K, Yoshino K (1989) Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 334:388–389
Miyajima Y, Nakamura H, Kuwata Y, Lee JD, Masunaga S, Ono K, Maruyama K (2006) Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy. Bioconjug Chem 17:1314–1320
Mollard A, Zharov I (2006) Tricarboranyl pentaerythritol-based building block. Inorg Chem 45:10172–10179
Nakamura H, Miyajima Y, Takei T, Kasaoka S, Maruyama K (2004) Synthesis and vesicle formation of a nido-carborane cluster lipid for boron neutron capture therapy. Chem Commun 1910-1911
Nigg DW (2003) Computational dosimetry and treatment planning considerations for neutron capture therapy. J Neurooncol 62:75–86
Nunez R, Gonzalex A, Vinas C, Teixidor F, Sillanpaa R, Kivekas R (2005) Approaches to the preparation of carborane-containing carbosilane compounds. Org Lett 7:231–233
Parrott MC, Marchington EB, Valliant JF, Adronov A (2005) Synthesis and properties of carborane-functionalized aliphatic polyester dendrimers. J Am Chem Soc 127:12081–12089
Qualmann B, Kessels MM, Musiol HJ, Sierralta WD, Jungblut PW, Moroder L (1996) Synthesis of boron-rich lysine dendrimers as protein labels in electron microscopy. Angew Chem Int Ed 35:909–911
Radin S, El-Bassyouni G, Vresilovic EJ, Schepers E, Ducheyne P (2005) In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials 26:1043–1052
Rao M, Trivillin VA, Heber EM, Cantarelli ML, Itoiz ME, Nigg DW, Rebagliati RJ, Batistoni D, Schwint AE (2004) BNCT of 3 cases of spontaneous head and neck cancer in feline patients. Appl Radiat Isot 61:947–952
Shipp DA, Wang JL, Matyjaszewski K (1998) Synthesis of acrylate and methacrylate block copolymers using atom transfer radical polymerization. Macromolecules 31:8005–8008
Soloway AH, Tjarks W, Barnum BA, Rong FG, Barth RF, Codogni IM, Wilson JG (1998) The chemistry of neutron capture therapy. Chem Rev 98:1515–1562
Sumitani S, Nagasaki Y (2012) Boron neutron capture therapy assisted by boron-conjugated nanoparticles. Polymer J 44:522–530
Sweet WH, Javid M (1951) The possible use of slow neutrons plus boron-10 in therapy of intracranial tumors. Trans Am Neurol Assoc 76:60–63
Thomas J, Hawthorne MF (2001) Dodeca(carboranyl)-substituted closomers: toward unimolecular nanoparticles as delivery vehicles for BNCT. Chem Commun 1884-1885
Tietze LF, Griesbach U, Bothe U, Nakamura H, Yamamoto Y (2002) Novel carboranes with a DNA binding unit for the treatment of cancer by boron neutron capture therapy. ChemBioChem 3:219–225
Tolpin EI, Wellum GR, Dophan FC, Kornblith PL, Zamenhof RG (1975) Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas. Oncology 32:223–246
Ueno M, Ban HS, Nakai K, Inomata R, Kaneda Y, Matsumura A, Nakamura H (2010) Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy. Bioorg Med Chem 18:3059–3065
Valliant JF, Guenther KJ, King AS, Morel R, Schaffer P, Sogbein OO, Stephson KA (2002) The medicinal chemistry of carboranes. Coord Chem Rev 232:173–230
van Blaaderen A, van Geest J, Vrij AJ (1992) Monodisperse colloidal silica spheres from tetraalkoxysilanes: particle formation and growth mechanism. Colloid Interface Sci 154:481–501
Woodhouse SL, Rendina LM (2001) Synthesis and DNA-binding properties of dinuclear platinum(II)-amine complexes of 1,7-dicarba-closo-dodecaborane(12). Chem Commun 23:2464–2465
Wu G, Barth RF, Yang W, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA (2004) Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug Chem 15:185–194
Yanagie H, Maruyama K, Takizawa T, Ishida O, Ogura K, Matsumoto T, Sakurai Y, Kobayashi T, Shinohara A, Rant J, Skvarc J, Ilic R, Kuhne G, Chiba M, Furuya Y, Sugiyama H, Hisa T, Ono K, Kobayashi H, Eriguchi M (2006) Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model. Biomed Pharmacother 60:43–50
Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ (2008) Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Cancer Res 14:883–891
Yao HJ, Grimes RN, Corsini M, Zanello P (2003) Polynuclear metallacarborane-hydrocarbon assemblies: metallacarborane dendrimers. Organometallics 22:4381–4383
Acknowledgments
This work was supported by the University of Utah Research Foundation through a Seed Grant and by the National Science Foundation (DMR-1008251). We are grateful to James K. Harper (University of Utah) for recording solid state NMR spectra.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brozek, E.M., Mollard, A.H. & Zharov, I. Silica nanoparticles carrying boron-containing polymer brushes. J Nanopart Res 16, 2407 (2014). https://doi.org/10.1007/s11051-014-2407-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-014-2407-1